T-PGI

Serial Number 98301836
606

Registration Progress

Application Filed
Dec 6, 2023
Under Examination
Oct 29, 2024
Approved for Publication
Sep 3, 2024
Published for Opposition
Sep 3, 2024
Registered

Attorney Assistance

Abandonment Notice E-Mailed - No Use Statement Filed
Due: Aug 02, 2025 24 days
Revival assistance for abandoned trademark

Basic Information

Serial Number
98301836
Deadline
August 2, 2025
Description
Trademark Application Revival Due
Filing Date
December 6, 2023
Published for Opposition
September 3, 2024
Abandonment Date
June 2, 2025
Drawing Code
4

Status Summary

Current Status
Inactive
Status Code
606
Status Date
Jun 2, 2025
Classes
001 005 042 044

Rights Holder

Tome Biosciences, Inc.

03
Address
100 Talcott Avenue
Watertown, MA 02472

Ownership History

Tome Biosciences, Inc.

Original Applicant
03
Watertown, MA

Tome Biosciences, Inc.

Owner at Publication
03
Watertown, MA

Legal Representation

Attorney
Jennifer Kwon

USPTO Deadlines

Next Deadline
24 days remaining
Abandonment Notice E-Mailed - No Use Statement Filed
Due Date
August 02, 2025

Application History

10 events
Date Code Type Description
Jun 2, 2025 MAB6 E ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Jun 2, 2025 ABN6 S ABANDONMENT - NO USE STATEMENT FILED
Oct 29, 2024 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Sep 3, 2024 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Sep 3, 2024 PUBO A PUBLISHED FOR OPPOSITION
Aug 14, 2024 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Aug 1, 2024 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER
Jul 6, 2024 DOCK D ASSIGNED TO EXAMINER
Mar 3, 2024 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Dec 6, 2023 NWAP I NEW APPLICATION ENTERED

Detailed Classifications

Class 001
Biological preparations for scientific use for use in gene therapy, gene editing, gene insertion, and cell therapy
Class 005
Pharmaceutical preparations and biological preparations for medical treatment for use in gene therapy, gene editing, gene insertion, and cell therapy for the treatment of genetic disorders; Pharmaceutical and biological preparations for the treatment of genetic disorders; Pharmaceutical and biological preparations based on gene, genome, and cellular editing, modulation, modification, regulation, and repair for use in human therapeutics
Class 042
Medical and scientific research; Medical research and development in the fields of genomic medicine, genome engineering, and cell engineering; Scientific research and development in the field of genomic medicine, genome engineering, and cell engineering; Research and development of pharmaceutical preparations for gene therapy, gene editing, gene insertion, and cell therapy; Providing medical and scientific research information in the fields of genomic medicine, genome engineering, and cell engineering
Class 044
Providing medical and healthcare information in the field of gene sequencing, gene editing, and gene insertion technologies; Providing medical and healthcare information regarding gene therapies and cell therapies

Additional Information

Pseudo Mark
TOME PGI

Classification

International Classes
001 005 042 044